We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

GlaxoSmithKline and OncoMed Form Strategic Alliance to Develop Cancer Stem Cell Antibody Therapeutics

News   Dec 11, 2007

 
GlaxoSmithKline and OncoMed Form Strategic Alliance to Develop Cancer Stem Cell Antibody Therapeutics
 
 
 

RELATED ARTICLES

Chemists Synthesize > 1 Million Macrocycles for Drug Discovery

News

Chemists from the University of Basel have built a rich collection of natural product-like macrocycles that can be mined for new medicines as the researchers.

READ MORE

How Undifferentiated Cells Commit to Their Biological Fate

News

The question of how primitive, undifferentiated cells choose their destiny has tantalized biologists for centuries. New clues about the molecular logic of cell fate show that multipotent cells become biased towards a fate early on and step through a progression of binary decisions as their fate is refined.

READ MORE

Synthesized Scorpion Venom Compounds Could Help Battle Bacterial Infections

News

A scorpion native to Eastern Mexico may have more than just toxin in its sting. Researchers at Stanford University and in Mexico have found that the venom also contains two color-changing compounds that could help fight bacterial infections.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE